6 unknown, 1 completed. 3 Phase 3, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Shenzhen Kangzhe Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema Mucopolysaccharide Polysulfate Cream, Mucopolysaccharide Polysulfate Cream and glucocorticoids - Eczema | Unknown | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 1800 | 2021-09-23 | 2022-06-30 | |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients Doxorubicin Hydrochloride Liposome Injection - Breast Cancer, Ovarian Cancer | Phase 1 | Unknown | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 80 | 2021-07-28 | 2022-03-10 |
| A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis Tildrakizumab 100 mg, Placebo - Plaque Psoriasis | Phase 3 | Completed | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 220 | 2020-12-17 | 2023-04-12 |
| A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition Oryz-Aspergillus Enzyme and Pancreatin Tablet, Placebo - Cirrhosis | Not applicable | Unknown | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 132 | 2019-08-30 | 2019-08-15 |
| Expanding Phase III Study of Tyroserleutide for Injection Gan Fu Le Tablets, Tyroserleutide for injection, Placebo - Hepatocellular Carcinoma | Phase 3 | Unknown | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 352 | 2016-03-24 | 2018-05-04 |
| Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients Tyroserleutide for injection ,chemotherapy(mitomycin, and Fluorouracil ), the placebo ,chemotherapy(mitomycin, and Fluorouracil ) - Hepatocellular,Carcinoma | Phase 3 | Unknown | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 300 | 2011-07-01 | 2011-12-14 |
| Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients mitomycin, Fluorouracil - Hepatocellular Carcinoma | Unknown | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 100 | 2007-12-01 | 2008-03-26 |
Carcinoma, Hepatocellular (3) · Breast Neoplasms (1) · Eczema (1) · Fibrosis (1) · Ovarian Neoplasms (1) · Recurrence (1)
Fluorouracil (2) · H-Tyr-Ser-Leu-OH (2) · Control Groups (1) · Glucocorticoids (1) · Hirudoid (1) · Injections (1) · Mitomycin (1) · Pancreatin (1) · tildrakizumab (1)
China (5)
Bie Ping, professor (1) · Chen Min Shan, professor (1) · Chen X P, Professor (1) · Chen Yan Ling, professor (1) · Ding Yi Tao, professor (1) · Dong Jia Hong, professor (1) · Du Qin, professor (1) · Fan Jia, professor (1) · Guo Rong Ping, professor (1) · Han Ying, professor (1) · Hao Xi Shan, Academician (1) · Jiang Bo, professor (1) · Li Wei, professor (1) · Lingfeng Li (1) · Liu Ji Yong, professor (1)